Zimmer Biomet Holdings Inc 2021 SR
The report highlights Zimmer Biomet's 2021 sustainability progress, including the approval of science-based targets to reduce Scope 1 and 2 emissions by 55% by 2030. A key milestone was the launch of the Prospero II solar farm, which offsets 100% of North American electrical load and helped achieve a 28% reduction in Scope 1 and 2 emissions. The company published its first SASB Index and noted that 10 major sites are now zero waste to landfill. Diversity efforts resulted in women representing 35.1% of the workforce and 30% of the Board. Additionally, 100% of team members completed ethics training, and the company achieved a 75% improvement in FDA product recalls compared to 2020.
Company: Zimmer Biomet Holdings Inc
Sector: Health Care
Country: United States
Year: 2021
Type: SR
Pages: 30
Zimmer Biomet Holdings Inc
Sustainability Report
The report highlights Zimmer Biomet's 2021 sustainability progress, including the approval of science-based targets to reduce Scope 1 and 2 emissions by 55% by 2030. A key milestone was the launch of the Prospero II solar farm, which offsets 100% of North American electrical load and helped achieve a 28% reduction in Scope 1 and 2 emissions. The company published its first SASB Index and noted that 10 major sites are now zero waste to landfill. Diversity efforts resulted in women representing 35.1% of the workforce and 30% of the Board. Additionally, 100% of team members completed ethics training, and the company achieved a 75% improvement in FDA product recalls compared to 2020.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Published
Mar 1, 2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees